Comparative modeling of HGPRT enzyme of L. donovani and binding affinities of different analogs of GMP

被引:27
作者
Ansari, Md Yousuf [1 ,2 ]
Dikhit, Manas Ranjan [1 ,2 ]
Sahoo, Ganesh Chandra [1 ,2 ]
Das, Pradeep [1 ,2 ]
机构
[1] Rajendra Mem Res Inst Med Sci, BioMed Informat Div, Patna 800007, Bihar, India
[2] Natl Inst Pharmaceut Educ & Res, Pharmacoinformat Dept, Hajipur, India
关键词
HGPRT; HGPRT inhibitor; Visceral leishmaniasis; Acyclovir monophosphate; Pentamidine; HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; VISCERAL LEISHMANIASIS; INHIBITOR DESIGN; PROTEIN; PREDICTION; DOCKING; ALGORITHM; ALIGNMENT; SITE;
D O I
10.1016/j.ijbiomac.2012.01.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypoxanthine-guanine phosphoribosyl transferase (HGPRT: EC 2.4.2.8) is a central enzyme in the purine recycling pathway. Parasitic protozoa (Leishmania donovani) cannot synthesize purines de novo and utilize the salvage pathway to produce purine bases. Thus, this enzyme is targeted in drug discovery and development. The model of the monomeric L donovani HGPRT showed that this enzyme is an alpha/beta type protein with a PRTase type I folding pattern. Among all of the computationally screened compounds, pentamidine, 1,3-dinitroadamantane, acyclovir and analogs of acyclovir had higher binding affinities than the real substrate (guanosine monophosphate). Amino acids of HGPRT that are frequently involved in the binding of these compounds are Lys 66, Asp 74, Arg 77, Asp 81, Val 88, Tyr 182, Arg 192 and,Arg 194. It is predicted that patients suffering from both HIV and visceral leishmaniasis (VL) may benefit if they are treated with acyclovir or pentamidine in conjunction with first-line antileishmanial therapies such as miltefosine and AmBisome. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:637 / 649
页数:13
相关论文
共 41 条
  • [1] Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
    Altschul, SF
    Madden, TL
    Schaffer, AA
    Zhang, JH
    Zhang, Z
    Miller, W
    Lipman, DJ
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (17) : 3389 - 3402
  • [2] BASIC LOCAL ALIGNMENT SEARCH TOOL
    ALTSCHUL, SF
    GISH, W
    MILLER, W
    MYERS, EW
    LIPMAN, DJ
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) : 403 - 410
  • [3] [Anonymous], 2009, J COMPUT SCI SYST BI, DOI DOI 10.4172/JCSB.1000026
  • [4] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [5] RRNA chemical groups required for aminoglycoside binding
    Blanchard, SC
    Fourmy, D
    Eason, RG
    Puglisi, JD
    [J]. BIOCHEMISTRY, 1998, 37 (21) : 7716 - 7724
  • [6] CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS
    BROOKS, BR
    BRUCCOLERI, RE
    OLAFSON, BD
    STATES, DJ
    SWAMINATHAN, S
    KARPLUS, M
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) : 187 - 217
  • [7] Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy
    Chugh, Pauline
    Bradel-Tretheway, Birgit
    Monteiro-Filho, Carlos Mr
    Planelles, Vicente
    Maggirwar, Sanjay B.
    Dewhurst, Stephen
    Kim, Baek
    [J]. RETROVIROLOGY, 2008, 5 (1)
  • [8] Geno3D:: automatic comparative molecular modelling of protein
    Combet, C
    Jambon, M
    Deléage, G
    Geourjon, C
    [J]. BIOINFORMATICS, 2002, 18 (01) : 213 - 214
  • [9] Purine salvage enzymes of parasites as targets for structure-based inhibitor design
    Craig, SP
    Eakin, AE
    [J]. PARASITOLOGY TODAY, 1997, 13 (06): : 238 - 241
  • [10] Drug resistance in leishmaniasis
    Croft, SL
    Sundar, S
    Fairlamb, AH
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2006, 19 (01) : 111 - +